All lobbying filings

Sandoz Inc.

Sandoz Inc. filed a Q4 report for Sandoz Inc. on January 20, 2026.

Lobbying for Sandoz Inc. · Pharmaceutical company

As filed: SANDOZ INC for SANDOZ INC.

All filings by Sandoz Inc. · Everything Sandoz Inc. has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Expenses

$140,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

New Jersey

Official filing document

Lobbyists on this filing 1

MICHAEL BARNARD New on this filing

Previously held: Legislative Coordinator, Sen Cantwell (June 2009 - August 2010); Legislative Assistant, Rep. Pastor (August 2010 - August 2011); Legislative Assistant, Sen. Menendez (August 2011 - Nov 2015) Sen. Policy Advisor, Sen. Menendez (Nov 2015 - May 2017)

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 5

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Medicare/Medicaid

Advocating to remove non-payer discounts from the ASP calculation for Medicare Part B Promoting a resilient pharmaceutical supply chain Advocating to amend Hatch-Waxman to limit brand companies from serially suing generic companies over the same molecule. issues related to generic and biosimilar access

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.